Gerald Mcmorrow
Principal investigator, leads VERAVANTI INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.2MFederal grants as PI6 awards
3Patents grantedLatest Aug 12, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 30, 2024 | NIH | SBIR Phase I Development of Quantitative In Vivo Imaging of Oral Biofilm pH to Allow Prevention of Enamel Demineralization | $309K | VERAVANTI INC. |
| Aug 25, 2022 | NIH | SBIR Phase II Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract | $1.0M | VERAVANTI INC. |
| Sep 23, 2021 | NIH | SBIR Phase II Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract | $993K | VERAVANTI INC. |
| Jun 23, 2017 | NIH | SBIR Phase I Optical visualization to efficiently guide coronary intervention of chronic total occlusions. | $286K | VERAVANTI INC. |
| May 15, 2017 | NIH | SBIR Phase I " Channel Multimodal Ultrathin Flexible SFE for cancer diagnosis and therapy" | $300K | VERAVANTI INC. |
| May 8, 2017 | NIH | SBIR Phase I "4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy" | $300K | VERAVANTI INC. |
4 patents as inventor
- US 11047671VERAVANTI INC.Jun 29, 2021
- US 11530910VERAVANTI INC.Dec 20, 2022
- US 12385733VERAVANTI INC.Aug 12, 2025
- US VERAVANTI INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#604
Awards as PI#349
Patents#124
Companies
- VERAVANTI INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.